M Pagliari

612 total citations
26 papers, 391 citations indexed

About

M Pagliari is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, M Pagliari has authored 26 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 7 papers in Surgery and 6 papers in Genetics. Recurrent topics in M Pagliari's work include Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (13 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (7 papers). M Pagliari is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Blood groups and transfusion (13 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (7 papers). M Pagliari collaborates with scholars based in Italy, Netherlands and Iran. M Pagliari's co-authors include Flora Peyvandi, Luciano Baronciani, Giovanna Cozzi, Ilaria Mancini, Cristina Novembrino, Francesca Stufano, Francesco Blasi, Stefano Aliberti, Valentina De Zan and Andrea Artoni and has published in prestigious journals such as Blood, PLoS ONE and Thrombosis and Haemostasis.

In The Last Decade

M Pagliari

26 papers receiving 381 citations

Peers

Countries citing papers authored by M Pagliari

Since Specialization

Citations

This map shows the geographic impact of M Pagliari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Pagliari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Pagliari more than expected).

Fields of papers citing papers by M Pagliari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Pagliari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Pagliari. The network helps show where M Pagliari may publish in the future.

Co-authorship network of co-authors of M Pagliari

This figure shows the co-authorship network connecting the top 25 collaborators of M Pagliari. A scholar is included among the top collaborators of M Pagliari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Pagliari. M Pagliari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A 2024 ·Blood Advances ·(unknown), Luca Mollica, (unknown), Luciano Baronciani, (unknown), (unknown), Giovanna Cozzi, M Pagliari, Alessandro Ciavarella, Simona Maria Siboni, Flora Peyvandi	8
2	Genetic determinants of enhanced von Willebrand factor clearance from plasma 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), Luciano Baronciani, M Pagliari, Giovanna Cozzi, (unknown), (unknown), Simona Maria Siboni, Eugenia Biguzzi, Flora Peyvandi	14
3	A comparative study in patients with type 2 von Willebrand disease using 4 different platelet-dependent von Willebrand factor assays 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Luciano Baronciani, Francesca Stufano, Giovanna Cozzi, (unknown), M Pagliari, Eugenia Biguzzi, Flora Peyvandi	6
4	Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study 2023 ·PLoS ONE ·Alberto Maino, Saeed Sadeghian, Ilaria Mancini, Seyed Hesameddin Abbasi, (unknown), Mohammad Ali Boroumand, Masoumeh Lotfi‐Tokaldany, Arash Jalali, M Pagliari, Frits R. Rosendaal, Flora Peyvandi	7
5	Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: a case-control study in Iran 2023 ·Research and Practice in Thrombosis and Haemostasis ·Pasquale Agosti, Ilaria Mancini, Saeed Sadeghian, M Pagliari, Seyed Hesameddin Abbasi, (unknown), Mohammadali Boroumand, Masoumeh Lotfi‐Tokaldany, Emanuela Pappalardo, Alberto Maino, Frits R. Rosendaal, Flora Peyvandi	5
6	Reply to “Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays” 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Luciano Baronciani, Giovanna Cozzi, M Pagliari, Eugenia Biguzzi, Flora Peyvandi	1
7	Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2 2022 ·Blood Advances ·(unknown), Luciano Baronciani, M Pagliari, Giovanna Cozzi, (unknown), (unknown), Simona Maria Siboni, Eugenia Biguzzi, Flora Peyvandi	17
8	The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients 2022 ·Haemophilia ·M Pagliari, Luciano Baronciani, Chiara Cordiglieri, (unknown), Giovanna Cozzi, Simona Maria Siboni, Flora Peyvandi	1
9	Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis 2021 ·PLoS ONE ·M Pagliari, (unknown), (unknown), Ilaria Mancini, Emanuela Pappalardo, Paolo Bucciarelli, Ida Martinelli, Frits R. Rosendaal, Flora Peyvandi	6
10	ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis 2020 ·Thrombosis Research ·M Pagliari, (unknown), (unknown), Ilaria Mancini, Ida Martinelli, Paolo Bucciarelli, Federica Rossi, Frits R. Rosendaal, Flora Peyvandi	15
11	The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients 2020 ·Journal of Thrombosis and Haemostasis ·Ilaria Mancini, Luciano Baronciani, Andrea Artoni, (unknown), (unknown), Giovanna Cozzi, Cristina Novembrino, (unknown), Valentina De Zan, M Pagliari, Roberta Gualtierotti, Stefano Aliberti, Mauro Panigada, Giacomo Grasselli, Francesco Blasi, Flora Peyvandi	149
12	Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpura 2019 ·Journal of Thrombosis and Haemostasis ·Barbara Ferrari, (unknown), M Pagliari, Ilaria Mancini, (unknown), Flora Peyvandi	7
13	The ISTH Bleeding Assessment Tool and the risk of future bleeding 2017 ·Journal of Thrombosis and Haemostasis ·Maria Rosaria Fasulo, Eugenia Biguzzi, Maria Abbattista, Francesca Stufano, M Pagliari, Ilaria Mancini, Marcin M. Gorski, Antonino Cannavò, (unknown), Flora Peyvandi, F.R. Rosendaal	28
14	Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis 2016 ·PLoS ONE ·M Pagliari, Luca A. Lotta, Hugoline G. de Haan, Carla Valsecchi, (unknown), Silvia Pontiggia, Ida Martinelli, Serena M. Passamonti, Frits R. Rosendaal, Flora Peyvandi	7
15	Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination 2015 ·Journal of Thrombosis and Haemostasis ·Francesca Stufano, Luciano Baronciani, M Pagliari, Franca Franchi, Giovanna Cozzi, (unknown), Paolo Bucciarelli, (unknown), Flora Peyvandi	8
16	The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura 2015 ·Thrombosis and Haemostasis ·M Pagliari, (unknown), Safwat Abdel‐Azeim, Edrisse Chermak, Ilaria Lazzareschi, Stefano Mastrangelo, Luigi Cavallo, Romina Oliva, Stefano Lancellotti, Flora Peyvandi, Raimondo De Cristofaro	15
17	Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels 2014 ·Journal of Thrombosis and Haemostasis ·Paolo Bucciarelli, Simona Maria Siboni, Francesca Stufano, Eugenia Biguzzi, Maria Teresa Canciani, Luciano Baronciani, M Pagliari, Silvia La Marca, Charles A. Mistretta, Frits R. Rosendaal, Flora Peyvandi	14
18	The type 2B p.R1306W natural mutation of von Willebrand factor dramatically enhances the multimer sensitivity to shear stress 2013 ·Journal of Thrombosis and Haemostasis ·Giovanni Luca Scaglione, Stefano Lancellotti, Massimiliano Papi, Marco De Spirito, Alessandro Maiorana, Luciano Baronciani, M Pagliari, Alessandro Arcovito, Enrico Di Stasio, Flora Peyvandi, Raimondo De Cristofaro	13
19	A synonymous (c.3390C>T) or a splice‐site (c.3380‐2A>G) mutation causes exon 26 skipping in four patients with von Willebrand disease (2A/IIE) 2013 ·Journal of Thrombosis and Haemostasis ·M Pagliari, Luciano Baronciani, (unknown), (unknown), Silvia La Marca, Giovanna Cozzi, Francesca Stufano, Maria Teresa Canciani, Flora Peyvandi	14
20	Interferon-β but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: A clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs 2011 ·Journal of Neuroimmunology ·Mario Rotondi, Francesca Stufano, Maria Stefania Lagonigro, Luigi La Manna, Francesca Zerbini, (unknown), M Pagliari, Francesca Coperchini, Flavia Magri, Roberto Bergamaschi, Antonio Oliviero, Luca Chiovato	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact